Ignite Creation Date:
2024-07-17 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06477523
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-19
Brief Title:
Phase 1b2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
Sponsor:
Sichuan University
Organization:
Sichuan University
Organization Data
Organization:
Sichuan University
Class:
OTHER
Study ID:
AK104-IIT-027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan University
Lead Sponsor Class:
OTHER
Responsible Party:
You Lu
Responsible Party Title:
Doctor of Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sichuan University
Old Name:
None
Old Organization:
None